Emergency contraceptive pills market to grow by 3.72% Y-O-Y from 2022 to 2023: Rise in the number of initiatives to create awareness will drive growth -Technavio

30 Jan 2023
www.prnewswire.com
NEW YORK, Jan. 30, 2023 /PRNewswire/ --
Emergency contraceptive pills market insights -
Continue Reading
Emergency contraceptive pills market to grow by 3.72% Y-O-Y from 2022 to 2023: Rise in the number of initiatives to create awareness will drive growth -Technavio
Preview
Source: PRNewswire
Technavio has announced its latest market research report titled Global Emergency Contraceptive Pills Market 2023-2027
Coverage: Key drivers, major trends, and challenges; customer and vendor landscape; vendor product insights and recent developments; key vendors; and market positioning of vendors
Segments: Distribution Channel (Retail stores and Online stores), Type (Combination pills and Progesterone pills), and Geography (North America, Europe, Asia, and Rest of World (ROW))
To understand more about the emergency contraceptive pills market,
request a sample report
The emergency contraceptive pills market report provides critical information and factual data, with a qualitative and quantitative study of the market based on market drivers and limitations as well as future prospects.
Why Buy?
Add credibility to the strategy
Analyzes competitor's offerings
Get a holistic view of the market
Grow your profit margin with Technavio-
Buy the Report
In 2017, the emergency contraceptive pills market was valued at
USD 831.35 million. From a regional perspective, North America held the largest market share, valued at
USD 281.00 million. The
emergency contraceptive pills market size is estimated to grow by USD 258.7 million from 2022 to 2027 at a CAGR of 4.83% according to Technavio.
Emergency contraceptive pills market insights - Customer Landscape
To help companies evaluate and develop growth strategies, the report outlines –
Key purchase criteria
Adoption rates
Adoption lifecycle
Drivers of price sensitivity
For highlights on customer landscape analysis,
download a sample
!
Global emergency contraceptive pills market - Vendor Insights
The growing competition in the market is compelling vendors to adopt various growth strategies such as promotional activities and spending on advertisements to improve the visibility of their services. Technavio report analyzes the market's competitive landscape and offers information on several market vendors including -
AbbVie Inc. - The company offers an emergency contraceptive pill, namely Liletta.
Afaxys Pharma LLC - The company offers emergency contraceptive pills namely Annovera.
Bayer AG: The company offers emergency contraceptive pills namely Yasmin.
Combe Inc.: The company offers emergency contraceptive pills namely Preventeza.
Global emergency contraceptive pills market –
Market Dynamics
Major drivers -
Rise in the number of initiatives to create awareness
Increase in unplanned pregnancies
Ease of online purchase
Key challenges -
Local governments limiting access to emergency contraceptive pills
Consumption and side effects
Availability of alternative methods of contraception
Drivers and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!
What are the key data covered in this emergency contraceptive pills market report?
CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the Emergency Contraceptive Pills Market between 2023 and 2027
Precise estimation of the size of the Emergency Contraceptive Pills Market size and its contribution to the market in focus on the parent market
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the Emergency Contraceptive Pills Market industry across North America, Europe, Asia, and Rest of World (ROW)
A thorough analysis of the market's competitive landscape and detailed information about vendors
Comprehensive analysis of factors that will challenge the growth of Emergency Contraceptive Pills Market vendors
Gain instant access to 17,000+ market research reports.
Technavio's SUBSCRIPTION platform
Related Reports:
The
female contraceptive market is estimated to grow at a CAGR of 5.32% between 2022 and 2027. The size of the market is forecasted to increase by USD 5,142.22 million. This report extensively covers market segmentation by distribution channel (offline and online), product (female contraceptive devices and female contraceptive drugs), and geography (North America, Europe, APAC, South America, and the Middle East and Africa).
The
emergency food market size is expected to decline by USD 2.88 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 7.23%. This report extensively covers segmentation by product type (ready-to-eat meals, non-perishable pasteurized milk, infant food, dried food, and others), distribution channel (offline and online), and geography (North America, Europe, APAC, South America, and Middle East and Africa).
Table of contents
1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary – Chart on Market Overview
Exhibit 02: Executive Summary – Data Table on Market Overview
Exhibit 03: Executive Summary – Chart on Global Market Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibit 06: Executive Summary – Chart on Market Segmentation by Type
Exhibit 07: Executive Summary – Chart on Incremental Growth
Exhibit 08: Executive Summary – Data Table on Incremental Growth
Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global emergency contraceptive pills market 2017 - 2021
Exhibit 18: Historic Market Size – Data Table on Global emergency contraceptive pills market 2017 - 2021 ($ million)
4.2 Distribution channel Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size – Distribution channel Segment 2017 - 2021 ($ million)
4.3 Type Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size – Type Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Distribution Channel
6.1 Market segments
Exhibit 30: Chart on Distribution Channel - Market share 2022-2027 (%)
Exhibit 31: Data Table on Distribution Channel - Market share 2022-2027 (%)
6.2 Comparison by Distribution Channel
Exhibit 32: Chart on Comparison by Distribution Channel
Exhibit 33: Data Table on Comparison by Distribution Channel
6.3 Retail stores - Market size and forecast 2022-2027
Exhibit 34: Chart on Retail stores - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Retail stores - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Retail stores - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Retail stores - Year-over-year growth 2022-2027 (%)
6.4 Online stores - Market size and forecast 2022-2027
Exhibit 38: Chart on Online stores - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Online stores - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Online stores - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Online stores - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Distribution Channel
Exhibit 42: Market opportunity by Distribution Channel ($ million)
7 Market Segmentation by Type
7.1 Market segments
Exhibit 43: Chart on Type - Market share 2022-2027 (%)
Exhibit 44: Data Table on Type - Market share 2022-2027 (%)
7.2 Comparison by Type
Exhibit 45: Chart on Comparison by Type
Exhibit 46: Data Table on Comparison by Type
7.3 Combination pills - Market size and forecast 2022-2027
Exhibit 47: Chart on Combination pills - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Combination pills - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Combination pills - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Combination pills - Year-over-year growth 2022-2027 (%)
7.4 Progesterone pills - Market size and forecast 2022-2027
Exhibit 51: Chart on Progesterone pills - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Progesterone pills - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Progesterone pills - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Progesterone pills - Year-over-year growth 2022-2027 (%)
7.5 Market opportunity by Type
Exhibit 55: Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 57: Chart on Market share by geography 2022-2027 (%)
Exhibit 58: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 59: Chart on Geographic comparison
Exhibit 60: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 81: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 85: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 France - Market size and forecast 2022-2027
Exhibit 89: Chart on France - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on France - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on France - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on France - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 93: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 97: Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 98: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 100: Overview on factors of disruption
11.4 Industry risks
Exhibit 101: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 102: Vendors covered
12.2 Market positioning of vendors
Exhibit 103: Matrix on vendor position and classification
Exhibit 104: AbbVie Inc. - Overview
Exhibit 105: AbbVie Inc. - Product / Service
Exhibit 106: AbbVie Inc. - Key news
Exhibit 107: AbbVie Inc. - Key offerings
Exhibit 108: Afaxys Pharma LLC - Overview
Exhibit 109: Afaxys Pharma LLC - Product / Service
Exhibit 110: Afaxys Pharma LLC - Key offerings
Exhibit 111: Bayer AG - Overview
Exhibit 112: Bayer AG - Business segments
Exhibit 113: Bayer AG - Key news
Exhibit 114: Bayer AG - Key offerings
Exhibit 115: Bayer AG - Segment focus
Exhibit 116: Combe Inc. - Overview
Exhibit 117: Combe Inc. - Product / Service
Exhibit 118: Combe Inc. - Key offerings
Exhibit 119: Foundation Consumer Healthcare LLC - Overview
Exhibit 120: Foundation Consumer Healthcare LLC - Product / Service
Exhibit 121: Foundation Consumer Healthcare LLC - Key offerings
12.8 Gedeon Richter Plc
Exhibit 122: Gedeon Richter Plc - Overview
Exhibit 123: Gedeon Richter Plc - Business segments
Exhibit 124: Gedeon Richter Plc - Key news
Exhibit 125: Gedeon Richter Plc - Key offerings
Exhibit 126: Gedeon Richter Plc - Segment focus
Exhibit 127: HLL Lifecare Ltd. - Overview
Exhibit 128: HLL Lifecare Ltd. - Product / Service
Exhibit 129: HLL Lifecare Ltd. - Key offerings
Exhibit 130: Laboratoire HRA Pharma SAS - Overview
Exhibit 131: Laboratoire HRA Pharma SAS - Product / Service
Exhibit 132: Laboratoire HRA Pharma SAS - Key offerings
Exhibit 133: Lupin Ltd. - Overview
Exhibit 134: Lupin Ltd. - Product / Service
Exhibit 135: Lupin Ltd. - Key news
Exhibit 136: Lupin Ltd. - Key offerings
Exhibit 137: Mankind Pharma Ltd. - Overview
Exhibit 138: Mankind Pharma Ltd. - Product / Service
Exhibit 139: Mankind Pharma Ltd. - Key offerings
Exhibit 140: Perrigo Co. Plc - Overview
Exhibit 141: Perrigo Co. Plc - Business segments
Exhibit 142: Perrigo Co. Plc - Key news
Exhibit 143: Perrigo Co. Plc - Key offerings
Exhibit 144: Perrigo Co. Plc - Segment focus
Exhibit 145: Pfizer Inc. - Overview
Exhibit 146: Pfizer Inc. - Product / Service
Exhibit 147: Pfizer Inc. - Key news
Exhibit 148: Pfizer Inc. - Key offerings
Exhibit 149: Piramal Enterprises Ltd. - Overview
Exhibit 150: Piramal Enterprises Ltd. - Business segments
Exhibit 151: Piramal Enterprises Ltd. - Key offerings
Exhibit 152: Piramal Enterprises Ltd. - Segment focus
Exhibit 153: Sun Pharmaceutical Industries Ltd. - Overview
Exhibit 154: Sun Pharmaceutical Industries Ltd. - Product / Service
Exhibit 155: Sun Pharmaceutical Industries Ltd. - Key offerings
Exhibit 156: Syzygy Healthcare LLC - Overview
Exhibit 157: Syzygy Healthcare LLC - Product / Service
Exhibit 158: Syzygy Healthcare LLC - Key offerings
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 159: Inclusions checklist
Exhibit 160: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 161: Currency conversion rates for US$
13.4 Research methodology
Exhibit 162: Research methodology
Exhibit 163: Validation techniques employed for market sizing
Exhibit 164: Information sources
13.5 List of abbreviations
Exhibit 165: List of abbreviations
About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
-
Targets
-
Drugs
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.